211 results
8-K
ABT
Abbott Laboratories
29 Jan 24
Entry into a Material Definitive Agreement
4:10pm
for Abbott and its subsidiaries, for which they have received, and may in the future receive, customary compensation and expense reimbursement.
Item … , for which they have received, and may in the future receive, customary compensation and expense reimbursement.
Item 2.03. Creation of a Direct
8-K
EX-99.1
vq7i3nkq2 bg99vl70
20 Jul 23
Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business
8:29am
PX14A6G
hiidn79
4 Apr 23
Letter to shareholders
7:15pm
8-K
EX-3.1
2tfscu 3gu
9 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
EX-3.1
iwaav5o3srg1y6g85ib9
15 Sep 22
Departure of Directors or Certain Officers
4:03pm
8-K
EX-99.1
63hj6
20 Apr 22
Abbott Reports First-Quarter 2022 Results
7:37am
PX14A6G
hby5jvaxp1vs skf9esq
21 Mar 22
Letter to shareholders
2:03pm
8-K
EX-3.1
oo7u8s3uhuu j5b46
22 Feb 22
Amendments to Articles of Incorporation or Bylaws
4:04pm
8-K
EX-99.1
bu8kw5p3i0brh7rsotvp
26 Jan 22
Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast
7:47am
8-K
EX-3.1
jge1fziff4dh1 at
10 Dec 21
Abbott Names Robert B. Ford Chairman of the Board; Miles D. White to Retire as Executive Chairman
4:34pm
8-K
EX-3.1
piok2589 5jtzpib2
1 Sep 21
Departure of Directors or Certain Officers
7:11am